| Trial ID: | L1364 |
| Source ID: | NCT00250536
|
| Associated Drug: |
Nandrolone Decanoate
|
| Title: |
Anabolic Steroids and Exercise in Hemodialysis Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
End-Stage Renal Disease|Muscle Weakness
|
| Interventions: |
DRUG: nandrolone decanoate|BEHAVIORAL: resistance exercise training
|
| Outcome Measures: |
Primary: Primary outcomes included change in lean body mass measured by dual-energy X-ray absorptiometry, quadriceps muscle cross-sectional area (CSA) measured by MRI, and knee extensor muscle strength. | Secondary: Secondary outcomes included changes in physical performance, self-reported physical functioning, and physical activity.
|
| Sponsor/Collaborators: |
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
80
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2000-03
|
| Completion Date: |
2004-10
|
| Results First Posted: |
|
| Last Update Posted: |
2010-01-14
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00250536
|
